Pkr Protein (Protein Kinase R) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Pkr Protein (Protein Kinase R) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox-protein
!! colspan="2" style="background:#f8f9fa; text-align:center; font-weight:bold" | PKR Protein (Protein Kinase R)
|-
! Gene
! UniProt
! PDB Structures
| 2E7O, 3UI8, 5Y36 |
|---|
! Molecular Weight
| ~62 kDa |
|---|
! Subcellular Localization
| Cytoplasm, nucleus |
|---|
! Protein Family
| Serine/Threonine Kinase |
|---|
PKR contains an N-terminal dsRNA-binding domain (DRBD) and a C-terminal serine/threonine kinase domain. The protein forms dimers upon dsRNA binding, leading to autophosphorylation and activation.
PKR is activated by double-stranded RNA and cellular stress. It phosphorylates eIF2alpha to inhibit protein synthesis in infected cells, acting as an antiviral defense. PKR also regulates apoptosis, differentiation, and innate immunity.
PKR is implicated in neurodegeneration through its role in protein synthesis regulation and apoptosis. In AD, PKR is activated in affected brain regions and may contribute to synaptic loss. In PD, PKR can be activated by alpha-synuclein aggregates. PKR knockout mice show altered responses to neurodegeneration models.
PKR inhibitors are being explored for neuroprotection. 2-aminopurine and C16 (a PKR inhibitor) have shown neuroprotective effects. However, PKR's antiviral role complicates therapeutic targeting.
Pkr Protein (Protein Kinase R) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Pkr Protein (Protein Kinase R) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.